[Pre Order] The Latest Pharmacology of Infectious Diseases & Immunizations Now with Critical Corona Virus Updates

$349.00 $125.00

The Latest Pharmacology of Infectious Diseases & Immunizations Now with Critical Corona Virus Updates

Product Delivery : You will receive a receipt download link WITHIN 14 DAYS through email.
Should you have any question, do not hesitate to contact me: [email protected]


The Latest Pharmacology of Infectious Diseases & Immunizations Now with Critical Corona Virus Updates

Sale page_


The world of pharmacology, infectious diseases, and immunizations is constantly evolving.

As new guidelines are released, modern evidence published, and critical information updated… are you confident you can keep up with it?

You can with our new-and-improved online course — The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Coronavirus Updates.

This self-paced video training gives you:

    1. Practice at the forefront of current infectious disease evidence


    1. Insights into WHY an agent should be prescribed in a clinical scenario


    1. The confidence to know WHEN it’s safe to use a cephalosporin in a patient with a history of penicillin reaction


    1. Tips to combat bacterial resistance — with an emphasis on new antimicrobials and advances in evidence-based treatment guidelines


    1. Skills to expertly interpret culture and sensitivity results


    1. Up to 13.75 total contact hours – INCLUDING 8.6 pharmacology CE hours


  1. …And so much more!


Gain the most up-to-date knowledge you will want to share with your colleagues!

Get started today and become the pharmacology expert on your unit by your very next shift!

It’s critical for your patients that you stay up-to-date on proper prescribing, patient education, and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases.

Here’s what you’ll cover in this state-of-the-art online training course:

Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians

— with Jason Cota, PharmaD, MS

  • Drug classes
  • Pharmacokinetic Properties
    • Concentration-dependent killing
    • Time-dependent killing
    • Post-antibiotic effect
  • Common interactions with other drugs
Antibacterial Allergies — Sulfa and Penicillin
  • Define true allergy
  • Sulfonamide antibiotics vs non-antibiotics
  • Penicillin — Cephalosporin cross-sensitivity
  • Differentiation
  • Normal flora
  • Common pathogens
Antibacterial Resistance — Contributing Factors
  • Trends
  • Mechanisms of resistance
  • Contributing factors
Methicillin-Resistant Staphylococcus Aureus —
Community versus Hospital Acquired
  • Differentiating between CA- and HA-MRSA
  • Current clinical practice guidelines
  • Pharmacologic management
Enterobacteriaceae Resistance
  • Extended Spectrum Beta-Lactamase (ESBL)
    • What are ESBLs
    • Pharmacologic management
  • Carbapenem-Resistant Enterobacteriaceae (CRE)
    • What are CREs
    • Pharmacologic management
Urinary Tract Infections
  • Bacterial Etiology, Signs and Symptoms and Diagnosis
  • Cystitis and pyelonephritis
  • Complicated and uncomplicated
  • UTIs in pregnancy
  • Treatment (IDSA Guideline Treatment Algorithm)
    • Acute
    • Recurrent and relapse
Clostridium Difficile Infection
  • Risk factors
  • Pharmacology management
  • Fecal Transplantation
  • Probiotics literature review
Community-Acquired Pneumonia
  • Bacterial etiology
  • Diagnosis
  • Typical vs. atypical
  • Treatment (IDSA/ATS Guidelines) and monitoring
    • Outpatient vs. inpatient
    • Empiric treatment
Healthcare-Associated Pneumonia
  • Bacterial etiology
  • Treatment (IDSA/ATS Guidelines)
Upper Respiratory Tract Infections
  • Sinusitis and pharyngitis
    • Etiology (Viral vs. Bacterial)
    • Treatment
Skin and Soft Tissue Infections
  • Cellulitis
  • Bacterial etiology
    • Strep. vs. Staph. vs. MRSA
    • Signs & symptoms
    • Treatment (IDSA Guidelines)
  • Clinical features
  • Diagnosis
  • Pharmacology management
Immunizations (Adult)
  • Types of Vaccines
  • General recommendations
  • Contraindications & precautions

Infection Control Challenges: Real Risks for Patients and Staff

— with William “Barry” Inman, BA-BS, CIC

A Summary of Current Recommendations From the CDC, SHEA, IDSA, APIC and the Joint Commission
Health-Care Associated Infections: Strategies to Control-Reduce-Eliminate
  • Catheter-Associated Urinary Tract Infections
  • Surgical Site Infections
  • Ventilator-Associated Pneumonias
  • Non-ventilator Associated Infections (overlooked HAI)
  • Central-Line Associated Bloodstream Infections
The Latest Multi-Drug Resistant Microorganism Guidelines
  • Carbapenem-resistant enterobacteriaceae
  • Clostridium difficile
  • Methicillin-resistant staphylococcus aureus
  • Vancomycin resistant enterococcus
  • Acinetobacter baumannii
  • Avian vs. swine vs. seasonal influenza
  • H1N1 pandemic results
  • When to treat? When not to treat?
  • Treatment with anti-virals and antibiotics
  • New vaccines for flu
Vaccination Recommendations for Healthcare Personnel
  • Zoster/shingles
  • Pneumoccocal
  • MMR, Tdap, etc.
Emerging Infectious Diseases (Zoonotic)
  • Ebola: What we learned
  • Mosquito-borne (“Zika”, Dengue, Chickungunya, West Nile)
  • Tick-borne (Lyme and Babesia)
  • Cryptosporidiosis
Bloodborne Pathogens
  • Hepatitis B
    • Vaccination protocol for healthcare personnel
    • Staff follow-up after significant exposures
    • Treatments for persons chronically infected
    • Outbreaks in healthcare
  • Hepatitis C
    • Treatment “cures” in 12-24 weeks
    • Outbreaks in healthcare-dialysis settings
    • New one pill daily treatment
    • Healthcare exposure and appropriate prophylaxis
  • Today’s best approaches to treatment
  • Skin testing vs. blood test for exposure
  • Follow-up guidelines for healthcare workers conversion testing
You’ll also get this Free bonus training!
Pharmacological Management of Infectious Diseases
— with Dr. Paul Langlois, APN, Ph.D., CCRN, CCNS, CNRN

Clinical expert Paul Langlois, APN, Ph.D., CCRN, CCNS, CNRN, knows that choosing an antibacterial agent can be challenging given the emerging trends in bacterial resistance.

In this incredible free training, Dr. Langlois discusses pharmacokinetic properties and new treatment guidelines for fungal infections, UTIs, pelvic inflammatory disease, cellulitis, diabetic foot infections, and multiple drug-resistant organisms. This video includes one additional pharmacology contact hour!

Cart Item Removed. Undo
  • No products in the cart.